LymphedemaV1, PubMed, Corpus, bibRecord, 002398

Prevalence and prognostic significance of secondary lymphedema following breast cancer.

Identifieur interne : 002398 ( PubMed/Corpus ); précédent : 002397; suivant : 002399

Prevalence and prognostic significance of secondary lymphedema following breast cancer.

Auteurs : Sandi Hayes ; Tracey Di Sipio ; Sheree Rye ; J Alejandro L Pez ; Christobel Saunders ; Chris Pyke ; John Bashford ; Diana Battistutta ; Beth Newman

Source :

Lymphatic research and biology [ 1557-8585 ] ; 2011.

RBID : pubmed:22066743

English descriptors

KwdEn :
- Adult, Aged, Breast Neoplasms (complications), Breast Neoplasms (mortality), Female, Humans, Kaplan-Meier Estimate, Lymphedema (epidemiology), Lymphedema (etiology), Middle Aged, Prevalence, Prognosis, Risk Factors, Time Factors.
MESH :
- complications : Breast Neoplasms.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- mortality : Breast Neoplasms.
- Adult, Aged, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Prevalence, Prognosis, Risk Factors, Time Factors.

Abstract

The adverse consequences of lymphedema following breast cancer in relation to physical function and quality of life are clear; however, its potential relationship with survival has not been investigated. Our purpose was to determine the prevalence of lymphedema and associated upper-body symptoms at 6 years following breast cancer and to examine the prognostic significance of lymphedema with respect to overall 6-year survival (OS).

DOI: 10.1089/lrb.2011.0007
PubMed: 22066743

Links to Exploration step

pubmed:22066743

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence and prognostic significance of secondary lymphedema following breast cancer.</title>
<author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
<affiliation><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Sipio, Tracey" sort="Di Sipio, Tracey" uniqKey="Di Sipio T" first="Tracey" last="Di Sipio">Tracey Di Sipio</name>
</author>
<author><name sortKey="Rye, Sheree" sort="Rye, Sheree" uniqKey="Rye S" first="Sheree" last="Rye">Sheree Rye</name>
</author>
<author><name sortKey="L Pez, J Alejandro" sort="L Pez, J Alejandro" uniqKey="L Pez J" first="J Alejandro" last="L Pez">J Alejandro L Pez</name>
</author>
<author><name sortKey="Saunders, Christobel" sort="Saunders, Christobel" uniqKey="Saunders C" first="Christobel" last="Saunders">Christobel Saunders</name>
</author>
<author><name sortKey="Pyke, Chris" sort="Pyke, Chris" uniqKey="Pyke C" first="Chris" last="Pyke">Chris Pyke</name>
</author>
<author><name sortKey="Bashford, John" sort="Bashford, John" uniqKey="Bashford J" first="John" last="Bashford">John Bashford</name>
</author>
<author><name sortKey="Battistutta, Diana" sort="Battistutta, Diana" uniqKey="Battistutta D" first="Diana" last="Battistutta">Diana Battistutta</name>
</author>
<author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:22066743</idno>
<idno type="pmid">22066743</idno>
<idno type="doi">10.1089/lrb.2011.0007</idno>
<idno type="wicri:Area/PubMed/Corpus">002398</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002398</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence and prognostic significance of secondary lymphedema following breast cancer.</title>
<author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name>
<affiliation><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Sipio, Tracey" sort="Di Sipio, Tracey" uniqKey="Di Sipio T" first="Tracey" last="Di Sipio">Tracey Di Sipio</name>
</author>
<author><name sortKey="Rye, Sheree" sort="Rye, Sheree" uniqKey="Rye S" first="Sheree" last="Rye">Sheree Rye</name>
</author>
<author><name sortKey="L Pez, J Alejandro" sort="L Pez, J Alejandro" uniqKey="L Pez J" first="J Alejandro" last="L Pez">J Alejandro L Pez</name>
</author>
<author><name sortKey="Saunders, Christobel" sort="Saunders, Christobel" uniqKey="Saunders C" first="Christobel" last="Saunders">Christobel Saunders</name>
</author>
<author><name sortKey="Pyke, Chris" sort="Pyke, Chris" uniqKey="Pyke C" first="Chris" last="Pyke">Chris Pyke</name>
</author>
<author><name sortKey="Bashford, John" sort="Bashford, John" uniqKey="Bashford J" first="John" last="Bashford">John Bashford</name>
</author>
<author><name sortKey="Battistutta, Diana" sort="Battistutta, Diana" uniqKey="Battistutta D" first="Diana" last="Battistutta">Diana Battistutta</name>
</author>
<author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name>
</author>
</analytic>
<series><title level="j">Lymphatic research and biology</title>
<idno type="eISSN">1557-8585</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Female</term>
<term>Humans</term>
<term>Kaplan-Meier Estimate</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Prognosis</term>
<term>Risk Factors</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Kaplan-Meier Estimate</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Prognosis</term>
<term>Risk Factors</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The adverse consequences of lymphedema following breast cancer in relation to physical function and quality of life are clear; however, its potential relationship with survival has not been investigated. Our purpose was to determine the prevalence of lymphedema and associated upper-body symptoms at 6 years following breast cancer and to examine the prognostic significance of lymphedema with respect to overall 6-year survival (OS).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22066743</PMID>
<DateCreated><Year>2011</Year>
<Month>11</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2011</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1557-8585</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>3</Issue>
<PubDate><Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>Lymphatic research and biology</Title>
<ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence and prognostic significance of secondary lymphedema following breast cancer.</ArticleTitle>
<Pagination><MedlinePgn>135-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2011.0007</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The adverse consequences of lymphedema following breast cancer in relation to physical function and quality of life are clear; however, its potential relationship with survival has not been investigated. Our purpose was to determine the prevalence of lymphedema and associated upper-body symptoms at 6 years following breast cancer and to examine the prognostic significance of lymphedema with respect to overall 6-year survival (OS).</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">A population-based sample of Australian women (n = 287) diagnosed with invasive, unilateral breast cancer was followed for a median of 6.6 years and prospectively assessed for lymphedema (using bioimpedance spectroscopy [BIS], sum of arm circumferences [SOAC], and self-reported arm swelling), a range of upper-body symptoms, and vital status. OS was measured from date of diagnosis to date of death or last follow-up. Kaplan-Meier methods were used to calculate OS and Cox proportional hazards models quantified the risk associated with lymphedema. Approximately 45% of women had reported at least one moderate to extreme symptom at 6.6 years postdiagnosis, while 34% had shown clinical evidence of lymphedema, and 48% reported arm swelling at least once since baseline assessment. A total of 27 (9.4%) women died during the follow-up period, and lymphedema, diagnosed by BIS or SOAC between 6-18 months postdiagnosis, predicted mortality (BIS: HR = 2.5; 95% CI: 0.9, 6.8, p = 0.08; SOAC: 3.0; 95% CI: 1.1, 8.7, p = 0.04). There was no association (HR = 1.2; 95% CI: 0.5, 2.6, p = 0.68) between self-reported arm swelling and OS.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest that lymphedema may influence survival following breast cancer treatment and warrant further investigation in other cancer cohorts and explication of a potential underlying biology.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayes</LastName>
<ForeName>Sandi</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. sc.hayes@qut.edu.au</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Di Sipio</LastName>
<ForeName>Tracey</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rye</LastName>
<ForeName>Sheree</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>López</LastName>
<ForeName>J Alejandro</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Saunders</LastName>
<ForeName>Christobel</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pyke</LastName>
<ForeName>Chris</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bashford</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Battistutta</LastName>
<ForeName>Diana</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Newman</LastName>
<ForeName>Beth</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Lymphat Res Biol</MedlineTA>
<NlmUniqueID>101163587</NlmUniqueID>
<ISSNLinking>1539-6851</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>11</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>11</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22066743</ArticleId>
<ArticleId IdType="doi">10.1089/lrb.2011.0007</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002398 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002398 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:22066743
   |texte=   Prevalence and prognostic significance of secondary lymphedema following breast cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:22066743" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Prevalence and prognostic significance of secondary lymphedema following breast cancer.

Prevalence and prognostic significance of secondary lymphedema following breast cancer.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki